
Viatris and Idorsia have announced that they have entered into agreements for a significant global research and development collaboration. Under …

The name for the new company emerging out of the merger between Pharma firm Mylan and Pfizer division Upjohn has …
Report highlights scope to expand day surgery
Sygnature formalises drug discovery collaboration with X-Chem
Codis appoints Steven Facer as chief commercial officer
Danish medical cannabis use rises as regulator reports no new safety signals

